Biologics Market Size, Share, Trends, Demand, Growth and Competitive Analysis| MarkNtel
MarkNtel Advisors recently published a detailed industry analysis of the Biologics Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Biologics Market Size, Share, and Trends
Analysis Report – Industry Overview and Forecast to 2030
The Biologics Market size was valued
at USD 412 Billion in 2024 and is projected to
reach USD 612 Billion by 2030. Along with this, the market is
estimated to grow at a CAGR of around 8.25% during the forecast period, i.e.,
2025-2030.
What are
the major Driver the Biologics industry?
Increasing Inclination Towards Gene Therapy
& Cellular Therapy to Boost the Market Growth – Due to their ability to repair or
substitute damaged tissues, gene and cellular treatments have experienced
considerable growth in adoption over the historical years. Moreover, the rising
investments in research & development of cell and gene therapies have been
further bolstering their adoption, owing to the improved efficacy of new drugs.
Additionally, there has been increased funding and investments for R&D
purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca
Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.
Thus, with
enhanced investment, the process of pre-commercialization and market launch has
been accelerated, which has been contributing to the market growth. Also, over
the historical years, the approvals of these medicines have been accelerated by
government organizations like the United States Food and Drug Administration
(FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for
cell and gene therapies would accelerate in the coming years, it would create
an opportunity for their enhanced adoption in the coming years as well.
Access the detailed PDF Sample report –
https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
What segments define the Biologics market
from 2025 to 2030? How do these segments contribute to market dynamics and
growth?
·
By Drug Class
- Recombinant Proteins- Market Size & Forecast 2020-2030, (USD
Million)
- Hormones- Market Size & Forecast 2020-2030, (USD Million)
- Cytokines- Market Size & Forecast 2020-2030, (USD Million)
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD
Million)
- Blood & Blood Components- Market Size & Forecast
2020-2030, (USD Million)
- Cellular & Gene Therapy- Market Size & Forecast 2020-2030,
(USD Million)
- Vaccines- Market Size & Forecast 2020-2030, (USD Million)
- Others- Market Size & Forecast 2020-2030, (USD Million)
According to report, Monoclonal Antibodies
(mAbs) have been gaining traction because of their capability to treat
illnesses such as cancers, autoimmune issues, and infections.
·
By Therapeutic Application
- Oncology- Market Size & Forecast 2020-2030, (USD Million)
- Infectious Disease- Market Size & Forecast 2020-2030, (USD
Million)
- Autoimmune Disease- Market Size & Forecast 2020-2030, (USD
Million)
- Diabetes- Market Size & Forecast 2020-2030, (USD Million)
- Cardiovascular Diseases- Market Size & Forecast 2020-2030,
(USD Million)
- Others (Inflammatory Bowel Diseases, Respiratory Disorders,
Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD
Million)
According to report, The Oncology segment
witnessed substantial market growth during historical years.
·
By Source
o
Microbes-
Market Size & Forecast 2020-2030, (USD Million)
o
Humans-
Market Size & Forecast 2020-2030, (USD Million)
o
Others
(Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)
Explore the Complete Biologics Market
Analysis Report – https://www.marknteladvisors.com/research-library/global-biologics-market.html
Geographical Analysis: Biologics Market
- Asia-Pacific
- North America
- South America
- Europe
- Middle East & Africa
Biologics Market Share & Competitive
Landscape:
The Biologics
Market is characterized by intense competition, with several key players
driving growth through innovation, market expansion, and strategic investments.
The competitive landscape provides valuable insights into the industry's
leading companies, highlighting their strengths, financial performance, and
market influence.
Leading Companies in the Biologics Market are:
·
Bristol-Myers
Squibb
·
Pfizer
·
Sanofi
·
Janssen
Biotech, Inc.
·
Bayer
AG
·
Merck
& Co.
·
Amgen
Inc.
·
Abbott
GmbH
·
Novartis
·
AstraZeneca
Plc
·
GlaxoSmithKline
Biologicals
·
Moderna,
Inc.
·
Ferring
Pharmaceuticals Inc.
·
Aimmune
Therapeutics, Inc.
·
F.
Hoffman La Roche
Biologics Industry Recent
Development:
- 2023: Amgen announced
the completion of the acquisition of biologics market player, Horizon
Therapeutics, which is aligned with its vision for the development of
drugs for patients with rare diseases.
- 2023: AstraZeneca
Plc. announced that the Ministry of Health, Labour, and Welfare in
Japan approved the extended utilization of Soliris (eculizumab) biologics
in the treatment of pediatric patients laid low with generalized
myasthenia gravis, particularly those who have no longer responded nicely
to different treatment options.
Questions Addressed in this
Study
1.What factors are
driving the Biologics Market growth?
2.How is the Biologics
Market expected to grow over the next five years?
3.What are the key
insights into the current trends in the Biologics Market?
4.What is the
current size of the Biologics Market, and how is it projected to change in the
future?
6.What is the
future outlook for the Biologics Market in terms of technological advancements
and market expansion?
For a Customized Analysis Report, Just Drop
Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html
Why MarkNtel Advisors?
MarkNtel Advisors
is a leading research, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.
Our specialization
in niche industries & emerging geographies allows our clients to formulate
their strategies in a much more informed way and entail parameters like
Go-to-Market (GTM), product development, feasibility analysis, project scoping,
market segmentation, competitive benchmarking, market sizing & forecasting,
& trend analysis, among others, for 15 diverse industrial verticals.
Others Reports:
More Research Studies Report:
-Biocomposites Market size was valued at around USD 36.9 billion in
2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around
16%.
-Green Solvents Market size was valued at around USD 1.34 billion in
2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around
5.7%.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91
120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven,
Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida,
Uttar Pradesh-201301, India
Comments
Post a Comment